UBM Announces Plans for Japan Pharma & Bio Events

By Cphi Japan, PRNE
Wednesday, March 3, 2010

AMSTERDAM, March 4, 2010 - Reflecting the growth in interest in the fine chemicals, pharmaceuticals
and bio-pharmaceuticals industries in what is the second largest
pharmaceutical market in the world after the United States, leading events
organiser UBM International Media and sister company UBM Japan Co. Ltd. today
announced details of their 2010 Japanese Pharma events roster. Spearheaded by
CPhI Japan (www.cphijapan.com/eng/), supported by ICSE Japan
(www.icsejapan.com/eng/), P-MEC Japan (www.pmec-japan.com/eng/)
and featuring a dedicated BioPharma Pavilion
(www.bioph-online.com/bioph-japan), these keynote events will take
place from 21-23 April at Tokyo's Big Sight Exhibition Center
(www.bigsight.jp/english/index.html), providing wide coverage and
great networking opportunities across all of the main pharma services

UBM's Japanese events have steadily expanded in size and increased in
terms of the number of exhibitors and visitors, stimulated by dynamic changes
in the Japanese pharmaceutical market such as the revision of Japan's
pharmaceutical law, growing competition from foreign companies, increased
merger and acquisition activity and the rise in demand for generic drugs.
With an estimated annual value of US$60 billion, a figure expected to rise,
according to IMS Health, to US$79 billion within five years, Japan's
pharmaceutical market will constitute approximately 11% of the total world
market in 2010.

CPhI Japan, launched in 2002, is the biggest pharmaceutical ingredients
exhibition held in Japan. The 2010 event features over 130 seminars and
exhibition presentations, including keynote sessions from Dr. Akihisa Chief
Scientist of Pfizer Japan Inc., who will focus on 'R&D Strategies for the
Next Generation' and Mr. Marc Dunoyer, Vice Chairman of EFPIA Japan and
Representative Director & Chairman, GlaxoSmithKline K.K., who will discuss
'Reducing the Drug Lag'.

UBM expects to equal or surpass the 2009 event, which saw almost 14,000
visitors and 425 exhibitors spanning 28 countries. Pre-registrations so far
for the 2010 event are up by 20% and leading exhibitors include BASF Japan,
Lonza AG, Dr. Reddy's, Abbott Japan Co., Mitsubishi, Sumitomo, and Misui.

One highlight at CPhI Japan 2010 is expected to be the BioPharma
Pavilion, which made its debut during CPhI Japan 2009 as a new concept
pavilion showcasing the most cutting-edge products and services to the
Japanese market. For 2010, the Pavilion has been extended, reflecting the
increasing convergence of pharma and biotech business models in global
healthcare, and the growing numbers of bio-pharma partnerships in drug
innovation, production and market delivery.

"The BioPharma pavilion and keynote and special seminar programmes were
extremely successful elements within CPhI Japan 2009," commented Eliane van
, UBM International Media's Group Director for Pharma events. "With the
biopharma industry assuming greater prominence in Japan for several reasons -
not least the country's aging population and the Government's increased focus
on the generics market as it bids to keep medical expenses under control -
Japanese pharmaceutical manufacturers are eager to catch up with competitors
from the US and Europe and are seeking to do so through investment and
cooperation with bio-ventures and universities. In addition, the Japanese
government has been investing in developing the domestic 'bio-infrastructure'
through funding bio-industrial cluster projects and setting up support
programs for bio-ventures and universities in order to enhance Japan's
biopharma industry. The BioPharma pavilion at CPhI Japan presents an ideal
platform, therefore, for the Japanese biopharma industry to meet potential
new partners from foreign countries."

Mirroring the significant growth in the demand for contract services in
the Japanese market, ICSE Japan has been co-located with CPhI Japan since
2005. In 2010, the ICSE Pavilion provides a unique opportunity to present new
products, outsourcing solutions or R&D development to the Japanese
pharmaceutical audience.

P-MEC Japan, with its focus on Pharma machinery and equipment will be
held for the 3rd time in tandem with CPhI Japan 2010 and is rapidly evolving
to embrace every aspect of pharma and biotech equipment and technology, from
packaging machinery, through laboratory and analytical techniques, to track
and trace technologies.

In Tokyo, there will be national pavilions for Italy, China, Korea, the
UK and India. Formal supporters of the event include Japan's Ministry of
Health, Labour and Welfare, the Ministry of Economy, Trade and Industry and
18 trade associations and industry organisations. The event's co-organiser is
The Chemical Daily Co. Ltd. - publisher of the highly respected Chemical
Daily and Japan Chemical Week.

UBM International Media's annual sister events for the pharma ingredients
and services sector include Worldwide (Europe - October); Japan (April);
China (June); and South America (August). For websites, see:
www.cphijapan.com, www.icsejapan.com and

Notes for Editors:

    -- UBM International Media operates market-leading global exhibition
       brands and their complementary media products.

    -- The CPhI pharmaceutical ingredients and related sector exhibitions
       currently number over 15 highly-regarded annual events. The
       portfolio also includes Informex (specialty chemicals), Food
       Ingredients, HBA (health & beauty industry) and Sea Trade (cruise

    -- Worldwide locations for its events include China, India, Japan, North
       America, Brazil, Africa and Europe. More than 330,000 business
       professionals and marketers visit UBM exhibitions each year. The
       exhibitions portfolio is managed from Holland. UBM International Media
       has approximately 1,200 employees in the UK, US, Asia and Europe. See

Media Enquiries: Impress PR, Europe: Richard Kerns, +44-161-728-5880; richard at impress-pr.com, North America: Mark Button. +1-503-616-3817, mark at impress-pr.com; Company Enquiries: UBM International Media, Rob Sahi (CPhI), Tel: +31-20-40-99-5561, or Ian O'Malley (ICSE, P-MEC, BioPh), +31-20-40-99-5526

will not be displayed